ARCHIVES

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

April 16, 2004

In Brief: Hopkins Gets $10 Million for Directorships, to Dedicate New Clinical Cancer Building

October 22, 1999

FDA Committee Approves Two NDAs, Blocks One, Hears NCI Toxicology Plan

June 15, 1979

HEW Ruling Limits Distribution Of Chemicals From Repository To Contractors, Government

May 7, 1976

MDV3100 Improves Survival, Reduces Death Risk by 37%

November 25, 2011

Frelick To Receive ACCC Annual Award Will Leave NCI In July

March 6, 1987